Researchers say elevated p-tau217 levels in older women were strongly linked to future dementia, raising hopes for earlier ...

In A Nutshell Women who took a combination of estrogen and progestin showed a stronger link between elevated p-tau 217 and dementia risk than those on placebo. A blood test measuring a protein called ...

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing ...

The outcome of the study revealed other interesting associations, too.

A long-term study of 2,766 women in the Women’s Health Initiative Memory Study found that higher baseline plasma p-tau217 levels were associated with a greater risk of developing mild cognitive ...

In real-world clinical practice, adding p‑tau217 testing significantly improved diagnostic accuracy and increased neurologists' diagnostic confidence, with marked reclassification seen in mild ...

UC San Diego researchers found a blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear, according to a paper published Tuesday.

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Asian Americans are the fastest-growing group of older adults in the U.S., but they often face language and cultural barriers when seeking care for dementia-related symptoms. As part of a broader ...

Donald Trump found himself at the center of another controversy after appearing to mischaracterize a routine cognitive screening as an advanced intelligence examination. The 79-year-old president made ...